At the time of writing, Health Catalyst Inc [HCAT] stock is trading at $2.27, down -3.62%. An important factor to consider is whether the stock is rising or falling in short-term value. The HCAT shares have lost -19.96% over the last week, with a monthly amount drifted -26.70%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on August 27, 2025, when Piper Sandler downgraded its rating to a Neutral but kept the price target unchanged to $4 for it. Previously, Citigroup downgraded its rating to Neutral on August 11, 2025. On August 08, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $4 on the stock. BTIG Research downgraded its rating to a Neutral. Evercore ISI downgraded its rating to a In-line. KeyBanc Capital Markets upgraded its rating to Overweight for this stock on January 08, 2025, but kept the price target unchanged to $9. In a note dated April 10, 2024, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
For the past year, the stock price of Health Catalyst Inc fluctuated between $2.20 and $9.24. Currently, Wall Street analysts expect the stock to reach $4.25 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $2.27 at the most recent close of the market. An investor can expect a potential return of 87.22% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
According to Health Catalyst Inc [NASDAQ:HCAT], the company’s sales were 316.06M for trailing twelve months, which represents an -0.04% plunge. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -0.32%, and Net Profit Margin reading is -0.32%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.28 and Total Capital is -0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.21 points at the first support level, and at 2.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.33, and for the 2nd resistance point, it is at 2.38.
Ratios To Look Out For
It is important to note that Health Catalyst Inc [NASDAQ:HCAT] has a current ratio of 1.86. On the other hand, the Quick Ratio is 1.86, and the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 0.51, the price to book ratio is 0.48.
Transactions by insiders
Recent insider trading involved Landry Benjamin, General Counsel, that happened on Sep 05 ’25 when 6175.0 shares were sold. Officer, BENJAMIN LANDRY completed a deal on Sep 05 ’25 to buy 6175.0 shares. Meanwhile, Officer Linda Llewelyn bought 2854.0 shares on Sep 02 ’25.
